Clinical Trials

FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata
Research & Development FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata

Imagine waking up each day to find more hair on your pillow than on your scalp, a stark reminder of an unseen battle within your body that strips away confidence. Alopecia areata (AA), an autoimmune condition, affects nearly 700,000 individuals in the United States, causing unpredictable hair loss

Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?
Research & Development Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in the realm of innovative technologies for neurological disorders. Today, we’re diving into the recent clinical trial results from Praxis Precision Medicines

Can U.S. Organ Transplant Reforms Restore Public Trust?
Research & Development Can U.S. Organ Transplant Reforms Restore Public Trust?

In a nation where thousands of lives hang in the balance awaiting organ transplants, the U.S. system has long been plagued by systemic failures that have eroded public confidence. Reports of operational flaws, lack of accountability, and even shocking practices—such as initiating organ donation

Two-Drug Combo Boosts Survival in Advanced Kidney Cancer
Research & Development Two-Drug Combo Boosts Survival in Advanced Kidney Cancer

Imagine a diagnosis of advanced kidney cancer, a condition once considered a near-certain death sentence due to limited treatment options, but today, groundbreaking research has shifted this narrative, offering renewed hope to thousands of patients worldwide. The focus of this progress lies in a

Can Donanemab Transform Early Alzheimer’s Treatment in Europe?
Management & Regulatory Can Donanemab Transform Early Alzheimer’s Treatment in Europe?

What if a single monthly infusion could halt the heartbreaking decline of memory and independence for millions of Europeans with early Alzheimer’s disease, bringing hope to families across the continent? This question, once a distant dream, now edges closer to reality with donanemab, a pioneering

Stanford Study Reveals Molecular Secrets of Brain Aging
Research & Development Stanford Study Reveals Molecular Secrets of Brain Aging

In a remarkable stride toward understanding the intricacies of brain aging, Stanford researchers have unveiled critical molecular insights through a study published in Science on July 30, offering new hope for future treatments. Under the leadership of Judith Frydman, the Donald Kennedy Chair in

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later